Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case–cross‐over study

BACKGROUND AND AIMS: Varenicline and nicotine replacement therapy (NRT) are the most commonly used medications to quit smoking. Given their widespread use, monitoring adverse risks remains important. This study aimed to estimate the neuropsychiatric and cardiovascular risks associated with varenicli...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Kyla H., Davies, Neil M., Taylor, Amy E., Taylor, Gemma M. J., Gunnell, David, Martin, Richard M., Douglas, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246946/
https://www.ncbi.nlm.nih.gov/pubmed/33197082
http://dx.doi.org/10.1111/add.15338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246946/
https://www.ncbi.nlm.nih.gov/pubmed/33197082
http://dx.doi.org/10.1111/add.15338

Ejemplares similares